Most Recent
St Vincent’s says applicant barred from bringing junior doctors class action
Sydney's St Vincent’s Hospital says the doctor leading a class action over alleged unpaid overtime can't bring the case because she did not file overtime claims.
Mayne loses bid for Corrs invoices ahead of costs fight with Cosette
Mayne Pharma cannot access invoices from Cosette’s solicitors at Corrs Chambers Westgarth, with a judge saying he was not hopeful that they would help to resolve a costs fight related to litigation over their collapsed $672 million merger.
Trial pushed back in AstraZeneca IP case against Pharmacor
Trial in AstraZeneca's patent infringement case over Pharmacor's plans to launch a cheaper version of diabetes drug Forxiga has been delayed to October, after the generic drug maker got the all-clear to revise its cross-claim.
Pharmacor can challenge patent term extension in AstraZeneca case
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.
Donors sue Monash IVF for transferring wrong embryo
A Western Australian couple has sued fertility services provider Monash IVF after the company implanted a woman with a different embryo than the one they had donated.
AstraZeneca accused of ‘royal commission’ into Pharmacor’s emails with lawyers
Pharmacor has accused AstraZeneca of launching a royal commission into emails with its lawyers as AstraZeneca opposes the generic drug maker's bid to amend its pleading in a patent case over diabetes drug Forxiga.
Class action alleges Pfizer knew of Depo-Provera’s brain tumor risks
US drug maker Pfizer has been hit with a class action alleging it knew or ought to have known about the increased risk that patients who used its injectable contraceptive Depo-Provera could develop brain tumors.
Egg donors cut from IVF rebates class action could revive claims, judge says
A judge has said women who donated eggs to their same-sex partners and were removed from a class action over IVF rebates could potentially revive their claims, but the lead applicant has not yet indicated whether she will pursue this path.
Australian Clinical Labs facing class action over data breach
Pathology services provider Australian Clinical Labs has been hit with a class action over a 2022 data breach that compromised the sensitive personal information of 223,000 customers of its Medlab business, including tests for fertility and STDs.
Telix sues to invalidate Purdue patent for cancer treatment Pluvicto
Melbourne-based biopharma Telix has filed a lawsuit against Purdue Research Foundation seeking to invalidate its patent for blockbuster prostate cancer treatment Pluvicto.